Gravitt PE[au] - Search Results

Year	Number of Results
1992	3
1993	2
1994	1
1995	1
1998	1
1999	1
2000	2
2001	4
2002	4
2003	7
2004	1
2005	4
2006	3
2007	6
2008	16
2009	13
2010	13
2011	21
2012	13
2013	22
2014	16
2015	9
2016	7
2017	10
2018	5
2019	9
2020	6
2021	9
2022	5
2023	1

1

Natural History of HPV Infection across the Lifespan: Role of Viral Latency.

Gravitt PE, Winer RL. Gravitt PE, et al. Viruses. 2017 Sep 21;9(10):267. doi: 10.3390/v9100267. Viruses. 2017. PMID: 28934151 Free PMC article. Review.

2

The vaginal metabolome and microbiota of cervical HPV-positive and HPV-negative women: a cross-sectional analysis.

Borgogna JC, Shardell MD, Santori EK, Nelson TM, Rath JM, Glover ED, Ravel J, Gravitt PE, Yeoman CJ, Brotman RM. Borgogna JC, et al. Among authors: gravitt pe. BJOG. 2020 Jan;127(2):182-192. doi: 10.1111/1471-0528.15981. Epub 2019 Nov 20. BJOG. 2020. PMID: 31749298 Free PMC article.

3

Barriers and innovative interventions for early detection of cervical cancer.

Baezconde-Garbanati L, Agurto I, Gravitt PE, Luciani S, Murphy S, Ochoa C, Gallegos K, Barahona R, Rodríguez Y. Baezconde-Garbanati L, et al. Among authors: gravitt pe. Salud Publica Mex. 2019 Jul-Aug;61(4):456-460. doi: 10.21149/10425. Salud Publica Mex. 2019. PMID: 31430087 Free PMC article.

4

Diagnosis and management of oncogenic cervical human papillomavirus infection.

Gravitt PE, Jamshidi R. Gravitt PE, et al. Infect Dis Clin North Am. 2005 Jun;19(2):439-58. doi: 10.1016/j.idc.2005.03.008. Infect Dis Clin North Am. 2005. PMID: 15963882 Review.

5

Secondary Prevention of Cervical Cancer: ASCO Resource-Stratified Guideline Update.

Shastri SS, Temin S, Almonte M, Basu P, Campos NG, Gravitt PE, Gupta V, Lombe DC, Murillo R, Nakisige C, Ogilvie G, Pinder LF, Poli UR, Qiao Y, Woo YL, Jeronimo J. Shastri SS, et al. Among authors: gravitt pe. JCO Glob Oncol. 2022 Sep;8:e2200217. doi: 10.1200/GO.22.00217. JCO Glob Oncol. 2022. PMID: 36162041 Free PMC article. Review.

6

Gut Helminth Infection-Induced Immunotolerance and Consequences for Human Papillomavirus Persistence.

Clark EH, Gilman RH, Chiao EY, Gravitt PE. Clark EH, et al. Among authors: gravitt pe. Am J Trop Med Hyg. 2021 Jul 19;105(3):573-583. doi: 10.4269/ajtmh.21-0191. Am J Trop Med Hyg. 2021. PMID: 34280146 Free PMC article. Review.

7

New technologies in cervical cancer screening.

Gravitt PE, Coutlée F, Iftner T, Sellors JW, Quint WG, Wheeler CM. Gravitt PE, et al. Vaccine. 2008 Aug 19;26 Suppl 10:K42-52. doi: 10.1016/j.vaccine.2008.05.002. Vaccine. 2008. PMID: 18847556 Review.

8

HPV Seroprevalence in the United States: Behavior, Biology, and Prevention.

Gravitt PE. Gravitt PE. J Infect Dis. 2016 Jan 15;213(2):171-2. doi: 10.1093/infdis/jiv405. Epub 2015 Aug 27. J Infect Dis. 2016. PMID: 26320258 Free PMC article. No abstract available.

9

Mechanistic mathematical models: An underused platform for HPV research.

Ryser MD, Gravitt PE, Myers ER. Ryser MD, et al. Among authors: gravitt pe. Papillomavirus Res. 2017 Jun;3:46-49. doi: 10.1016/j.pvr.2017.01.004. Epub 2017 Feb 4. Papillomavirus Res. 2017. PMID: 28720456 Free PMC article. Review.

10

The known unknowns of HPV natural history.

Gravitt PE. Gravitt PE. J Clin Invest. 2011 Dec;121(12):4593-9. doi: 10.1172/JCI57149. Epub 2011 Dec 1. J Clin Invest. 2011. PMID: 22133884 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results